Text Size

Postoperative Troponin in Children With Congenital Heart Disease

This study is currently recruiting participants.
Verified June 2012 by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Sponsor:
Information provided by (Responsible Party):
Momeni, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT01616394
First received: February 8, 2012
Last updated: June 7, 2012
Last verified: June 2012
History of Changes
  Purpose

The aim of the study is to evaluate the value of postoperative troponin in the prediction of short term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.


Condition
Congenital Heart Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Heart Diseases
U.S. FDA Resources

Further study details as provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain:

Primary Outcome Measures:
  • mortality [ Time Frame: 3 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • morbidity [ Time Frame: in hospital; 3 months; 6 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 250
Study Start Date: February 2012
Estimated Study Completion Date: February 2015
Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
children with congenital heart disease

  Eligibility

Ages Eligible for Study:   up to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

children with congenital heart disease admitted for surgery

Criteria

Inclusion Criteria:

  • all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery

Exclusion Criteria:

  • parental refusal
  • children older than 10 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01616394

Contacts
Contact: Mona MOMENI, MD +3227641821 mona.momeni@uclouvain.be

Locations
Belgium
Cliniques Universitaires saint Luc Recruiting
Brussels, Belgium, 1200
Contact: Mona MOMENI, MD     +3227641821     mona.momeni@uclouvain.be    
Principal Investigator: Mona MOMENI, MD            
Sponsors and Collaborators
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Investigators
Principal Investigator: Mona MOMENI, MD Cliniques universitaires Saint-Luc- Université Catholique de Louvain
  More Information

No publications provided

Responsible Party: Momeni, MD; Chef de Clinique Adjointe, Department of Anesthesiology, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier: NCT01616394     History of Changes
Other Study ID Numbers: 2011/07/DEC/460
Study First Received: February 8, 2012
Last Updated: June 7, 2012
Health Authority: Belgium: Institutional Review Board

Additional relevant MeSH terms:
Heart Diseases
Heart Defects, Congenital
Cardiovascular Diseases
Cardiovascular Abnormalities
Congenital Abnormalities

ClinicalTrials.gov processed this record on May 21, 2013